AbCellera Biologics (ABCL) Operating Leases (2020 - 2026)
AbCellera Biologics (ABCL) posted Operating Leases of $129.95 million for Q2 2026, down 5.3% from $137.18 million a year earlier and down 3.2% from the prior quarter.
Powered by 
Analysis
AbCellera Biologics (ABCL) Operating Leases (2020 - 2026) Analysis & Trends
At the end of FY2025, AbCellera Biologics' Operating Leases came in at $137.4 million, up 126.2% from FY2024.
- Annual Operating Leases shows a five-year compound annual growth rate of 105.9% (FY2020 to FY2025).
- In prior years, AbCellera Biologics' Operating Leases was $60.74 million in FY2024 (-14.7%), $71.22 million in FY2023 (-7.1%), $76.68 million in FY2022 (+110.6%) and $36.41 million in FY2021 (+880.2%).
- The Q2 2026 figure stands as the lowest quarterly Operating Leases since Q1 2025.
- On a year-over-year basis, Operating Leases increased in four of the last eight quarters, with growth averaging 51.6%.
- The strongest year-over-year quarter for Operating Leases in the past five years was Q4 2021, with growth of 880.2%; the weakest was Q2 2024, with a decline of 14.9%.
- According to Business Quant data, Operating Leases for the three prior quarters was $134.31 million (Q1 2026), $137.4 million (Q4 2025) and $137.05 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn |
| 10 | AbCellera Biologics | 3.83 Bn | 3.29 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 129.95 Mn |
| Mar 31, 2026 | 134.31 Mn |
| Dec 31, 2025 | 137.40 Mn |
| Sep 30, 2025 | 137.05 Mn |
| Jun 30, 2025 | 137.18 Mn |
| Mar 31, 2025 | 63.21 Mn |
| Dec 31, 2024 | 60.74 Mn |
| Sep 30, 2024 | 66.27 Mn |
| Jun 30, 2024 | 66.45 Mn |
| Mar 31, 2024 | 68.08 Mn |
| Dec 31, 2023 | 71.22 Mn |
| Sep 30, 2023 | 75.19 Mn |
| Jun 30, 2023 | 78.08 Mn |
| Mar 31, 2023 | 77.27 Mn |
| Dec 31, 2022 | 76.68 Mn |
| Sep 30, 2022 | 71.59 Mn |
| Jun 30, 2022 | 32.76 Mn |
| Mar 31, 2022 | 36.36 Mn |
| Dec 31, 2021 | 36.41 Mn |
| Sep 30, 2021 | 27.26 Mn |
API Access
AbCellera Biologics Operating Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-leases&ticker=ABCL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-leases", "ticker": "ABCL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-leases&ticker=ABCL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();